Jubilant Pharmaceuticals is the European subsidiary of Jubilant Organosys Ltd. (India), specialists in the R&D and production of API's and finished dosage form products. We are a totally backward integrated service and product provider for generic pharmaceutical companies who wish to excel in first-to-market generics with a commitment to market-competitive prices during the entire term of the Supply Agreement. Our core business and capabilities are situated in the below areas: * Out-licensing with supply of fully in-house developed generics, covering a wide range of therapeutic areas * Regulatory Services such as MRP & DCP filings, compilation of e-CTD dossiers, etc * Manufacturing site transfers with production at the in- house EU-GMP approved plant in Roorkee, India * Clinical research at the in-house facility in Delhi, India We are a one-stop-solution through full integration of in-house API, R&D formulation, clinical center, regulatory affairs expertise, EU-GMP approved dosage form manufacturing and GDP logistics followed by EU-release.
View Top Employees from Jubilant PharmaceuticalsWebsite | http://www.jubilant.be |
Revenue | $5 million |
Employees | 23 (5 on RocketReach) |
Technologies | |
Industry | Manufacturing General, Generics, Manufacturing, Backward Integrated, Pharmaceuticals, Europe, Regulatory Affairs, Supply Chain |
SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32541 Companies |
Looking for a particular Jubilant Pharmaceuticals employee's phone or email?
The Jubilant Pharmaceuticals annual revenue was $5 million in 2024.
m.sc Ram Mullur is the Director of Business Development of Jubilant Pharmaceuticals.
5 people are employed at Jubilant Pharmaceuticals.
Jubilant Pharmaceuticals is based in Merelbeke, Oost-Vlaanderen.
The NAICS codes for Jubilant Pharmaceuticals are [32, 3254, 325, 32541].
The SIC codes for Jubilant Pharmaceuticals are [28, 2834, 283].